Back to Search
STEFAN FADERL, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1689770844Individual
Specialties, Licenses & Credentials
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
K7015(TX)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
25MA09307400(NJ)
Research & Publications (20)
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 Years.
PMID 19646755·Leuk Res·2010
3-trial
Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy.
PMID 19298009·Cancer·2009
8-other
Treatment of B-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy.
PMID 18987653·Leukemia·2009
6-review
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients.
PMID 18827183·Blood·2009
8-other
Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience.
PMID 19340529·Int J Hematol·2009
8-other
Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure.
PMID 19517473·Cancer·2009
3-trial
Survival is poorer in patients with secondary core-binding factor acute myelogenous leukemia compared with de novo core-binding factor leukemia.
PMID 19441109·Cancer·2009
8-other
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.
PMID 19439093·J Hematol Oncol·2009
3-trial
Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells.
PMID 19383925·Cancer Res·2009
8-other
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens.
PMID 19090005·Cancer·2009
8-other
Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin.
PMID 19075265·J Clin Oncol·2009
8-other
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy.
PMID 19060245·Blood·2009
3-trial
Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens.
PMID 19050308·Blood·2009
3-trial
Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia.
PMID 18703706·Blood·2009
8-other
Significance of suboptimal response to imatinib, as defined by the European LeukemiaNet, in the long-term outcome of patients with early chronic myeloid leukemia in chronic phase.
PMID 19517462·Cancer·2009
8-other
Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome.
PMID 19242494·Leukemia·2009
3-trial
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia.
PMID 18931344·Blood·2009
3-trial
Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment.
PMID 19224852·J Clin Oncol·2009
8-other
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome.
PMID 19151791·Bone Marrow Transplant·2009
3-trial
Outcome of adults with acute lymphocytic leukemia after second salvage therapy.
PMID 18846563·Cancer·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 92 SECOND ST.
HACKENSACK, NJ 07601 - Phone
- (551) 996-3925
Quick Facts
- NPI
- 1689770844
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile